Adolescent Medicine News

Despite widespread support for mental health training in schools, less than half of Americans believe most school staff have received it, according to the results of a recent poll by the American Psychiatric Association.

Lower levels of S100 proteins at baseline predict better treatment response with abatacept in patients with polyarticular-course juvenile idiopathic arthritis, according to data published in Arthritis Research & Therapy.

Receiving daily text messages as part of an e-cigarette cessation intervention led to a larger vaping abstinence rate at 7 months vs. a control treatment in adolescents, according to results published in JAMA.

In this episode, host Hansa Bhargava, MD, discusses computer science and technology in medicine and the inequities and lack of preventive care in pediatrics with Sharief Taraman, MD.

A brief, disease-tailored intervention reduced alcohol use among vulnerable adolescents with chronic medical conditions, according to a study published in JAMA Network Open.

A recently published case report summarized the successful initiation of buprenorphine treatment in two adolescents who presented to a pediatric ED with opioid withdrawal.

Tofacitinib’s benefits in patients with juvenile idiopathic arthritis extend through at least 48 months, with no new safety findings, according to data published in Annals of the Rheumatic Diseases.

More than one-quarter of sexually active adolescents who accessed care in EDs reported not using contraception, raising their risk for pregnancy, according to a study published in JAMA Network Open.

Fatigue partially mediates the relationship between pain interference and physical disability in juvenile idiopathic arthritis, according to data published in Arthritis Care & Research.

Healio has launched a new special report on medical cannabis that summarizes the current scientific research and incorporates expert opinion.